Bausch & Lomb CEO departs Oct 12, 2026
- Brent Saunders departs as CEO and board member effective Oct 12, 2026.
- Thomas J. Appio appointed interim CEO, also CEO of Bausch Health.
- $75.5M lump-sum cash payment to Saunders under separation agreement.
Every EDGAR filing for Bausch & Lomb Corp (BLCO), newest first, with AI summaries and stories.
Next: earnings expected ~Oct 30 · 10-Q expected ~Oct 30 (deadline Nov 9)
Karen Ling, planned sale of BLCO shares
Karen Ling, reporting
Barbara Trebbi, insider filing for BLCO
Barbara Trebbi, reporting
Frederick Munsch, insider filing for BLCO
Frederick Munsch, reporting
Frederick Munsch, planned sale of BLCO shares (amended)
Frederick Munsch, reporting
Eschenbach Andrew C. Von, insider filing for BLCO
Eschenbach Andrew C. Von, reporting
Frederick Munsch, planned sale of BLCO shares
Frederick Munsch, reporting
Eschenbach Andrew C. Von, planned sale of BLCO shares
Eschenbach Andrew C. Von, reporting
Andrew J. Stewart, insider filing for BLCO
Andrew J. Stewart, reporting
Eschenbach Andrew C. Von, planned sale of BLCO shares
Eschenbach Andrew C. Von, reporting
Luc Bonnefoy, insider filing for BLCO
Luc Bonnefoy, reporting
Eschenbach Andrew C. Von, insider filing for BLCO
Eschenbach Andrew C. Von, reporting
Brent L Saunders, insider filing for BLCO
Brent L Saunders, reporting
Sam Eldessouky, insider filing for BLCO
Sam Eldessouky, reporting
Russel C Robertson, insider filing for BLCO
Russel C Robertson, reporting
Andrew J. Stewart, insider filing for BLCO
Andrew J. Stewart, reporting